|3Sep 17, 9:37 PM ET

OrbiMed Capital GP V LLC 3

3 · Adicet Bio, Inc. · Filed Sep 17, 2020

Insider Transaction Report

Form 3
Period: 2020-09-15
Holdings
  • No securities are beneficially owned

    (indirect: See Footnote)
    0
Footnotes (1)
  • [F1]This report is being jointly filed by OrbiMed Capital GP V LLC, OrbiMed Israel BioFund GP Limited, OrbiMed Israel GP Ltd., OrbiMed Israel Partners II, L.P., and OrbiMed Israel GP II, L.P. The Reporting Persons have designated Carl L. Gordon ("Gordon") and Erez Chimovits ("Chimovits") to serve on the Issuer's board of directors. This report shall not be deemed an admission that any of the Reporting Persons, Gordon, or Chimovits is a beneficial owner of the Issuer's securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.

Documents

1 file
  • 3
    ownership.xmlPrimary